Brain Inflammation | Stop These Three Diseases Before They Start

Richard Isaacson and Mark Hyman detail the components of a brain-healthy diet. DHA makes up 60% of the brain and is crucial for APOE4 carriers. Monounsaturated fats like olive oil are anti-amyloid. Berries, per the Nurses' Health Study, can delay cognitive decline by two years with regular consumption. They stress personalization: some may need a ketogenic approach, others do better with more carbs if active. The 'elf diet' (eat less food) is also mentioned, with calorie restriction around 2100 calories/day associated with delayed decline, but not at the expense of muscle mass. They advocate for plant-rich, not necessarily vegan, and quality protein sources.

Isaacson notes that 60% of people in Miami are vitamin D deficient despite sun. He recommends testing and supplementing if needed. Omega-3s, especially DHA, are vital for APOE4 carriers to prevent cognitive decline. They don't give universal doses; it's personalized.

Isaacson's study used an intensive, personalized approach. They tested one intervention at a time (N-of-1) and measured 150 biomarkers. The multimodal group saw the greatest improvements. This suggests that stacking multiple lifestyle changes has a synergistic effect.

Isaacson's team tracks women with multiple blood draws across the menstrual cycle to understand how hormone fluctuations affect p-tau217. They've started women as young as 42 on low-dose HRT when estrogen declines and tau rises, even if asymptomatic. They've seen improvements in amyloid, tau, cholesterol, and symptoms. He argues that perimenopause is a neurological condition, and it's unethical to let women suffer. The approach is precision-based: correct biomarker interpretation by cycle day.

Hyman's patient improved dramatically, but Isaacson cautions that he's seen others go the wrong way. This underscores the need for personalized nutrition. The diet shifts brain metabolism from glucose to ketones, which can bypass insulin resistance in the brain.

Dorsey and Oaken explain the historical link and modern evidence. They note that Parkinson's is rising dramatically, and air pollution is a likely driver. While individual avoidance helps, systemic change is crucial.

Palmer explains the biological embedding of trauma and the gut-brain axis. He notes that even if trauma is the root cause, dietary interventions can help restore a healthy microbiome, offering a complementary approach.

Mark Hyman describes a patient with MCI who improved with comprehensive functional medicine but then started declining again. He suggested a ketogenic diet, which he had been reading about for its effects on brain metabolism. After implementing a diet of 75% fat, cutting out sugar and starch, her cognitive function dramatically improved, 'like the lights came back on.' This suggests that for some individuals, shifting brain fuel from glucose to ketones can restore function when other fixes are insufficient. Hyman emphasizes that this is not a one-size-fits-all; Richard Isaacson notes he's had patients who worsened on ketogenic diets, underscoring the need for personalization.

Richard Isaacson presented data at the 2025 Alzheimer's Association International Conference showing that in their study, intensive lifestyle intervention—including exercise, nutrition, vitamins, supplements, sleep modification, stress management, learning new things, and regular doctor visits to optimize blood pressure, cholesterol, and blood sugar—produced statistically significant improvements in pathologic proteins associated with neurodegenerative disease. This outperformed any drug interventions, including GLP-1 agonists and amyloid drugs. The study used rigorous N-of-1 designs, testing one intervention at a time and measuring 150 biomarker proteins in duplicate. Isaacson emphasizes that this personalized, multimodal approach is more effective than population-based drug trials.

Richard Isaacson's team has been tracking women through perimenopause, measuring estrogen, progesterone, and brain biomarkers like p-tau217 across menstrual cycles. They found that as estrogen drops, amyloid and tau rise, even before symptoms are severe. By starting low-dose bioidentical HRT early, they've seen improvements in these biomarkers, cholesterol, and cognitive symptoms. He argues that perimenopause is a neurological condition, not just hot flashes, and that waiting until symptoms are debilitating is a disservice. The approach is personalized: they monitor biomarkers every 6-12 months and intervene when estrogen declines and tau rises, even if the woman feels fine. This is especially critical for APOE4 carriers. He notes that their research is unique—no one else is doing multiple blood draws across the menstrual cycle to correct biomarker interpretation based on hormone levels.

Ray Dorsey and Michael Oaken explain that James Parkinson's 1817 description of the disease was of something new, at a time when London's air quality was as bad as modern-day Delhi. Coal burning released mercury and lead, and today's air pollution contains particulate matter carrying toxic metals like lead from gasoline, iron from brakes, platinum from catalytic converters. These particles, smaller than 1/30th the width of a hair, can penetrate the olfactory nerve—a direct route to the brain bypassing the blood-brain barrier. Autopsies show high levels of heavy metals in the brains of Parkinson's patients. They also note that Parkinson's is a whole-body disease, with misfolded proteins found in the gut and skin, and increased risk of melanoma and osteoporosis. This challenges the myth that it's just a brain disease of dopamine deficiency.

Chris Palmer and Mark Hyman discuss how the brain only has so many ways of saying 'ouch,' and inflammation manifests as psychiatric symptoms. Palmer explains that high inflammation triggers sickness behavior—fatigue, social withdrawal, anhedonia—which is adaptive during infection but becomes pathological when chronic. He notes that COVID-19 caused severe neuroinflammation, leading to depression and even suicidality in some. Hyman shares his personal experience: after COVID, he felt severely depressed and suicidal, but exosomes resolved it in a day. They emphasize that many roads lead to inflammation: diet, toxins, stress, microbiome changes, infections. The final common pathway is mitochondrial dysfunction and energy dysregulation in brain cells.

Chris Palmer defines metabolism not just as burning calories but as the fundamental process of converting food into energy and building blocks, essential for life. The cessation of metabolism is death. He argues that all causes of death—suffocation, starvation, toxins—disrupt metabolism. Cyanide, arsenic, Tylenol overdose, alcohol poisoning are all mitochondrial toxins. Therefore, dysregulation of metabolism leads to chronic disease. Mitochondria are the key regulators. This applies to mental disorders: diet, stress, trauma, toxins all impair mitochondrial function in the brain, leading to symptoms. He acknowledges criticism of being reductionistic but insists it's a law of biology. This framework explains why diverse interventions like diet, exercise, and stress reduction can treat conditions from depression to Alzheimer's.

Chris Palmer explains that ACEs, if severe enough, increase risk for all mental disorders, including autism, as well as obesity, diabetes, cardiovascular disease, and autoimmune conditions. The mechanism: trauma gets 'written in your epigenome' and biology, turning on genes that drive inflammation, oxidative stress, and insulin resistance. He cites their research showing amygdala activation (threat response) signals via the vagus nerve to Brunner's glands in the gut, altering acidity and the microbiome. This means stress changes the gut, which then impacts whole-body health. However, diet can also modify the gut microbiome, offering a treatment avenue even when trauma is the root cause.

Michael Oaken and Mark Hyman discuss how the concept of a leaky gut was once ridiculed but is now accepted. Similarly, the blood-brain barrier can become permeable. Oaken explains that the olfactory nerve provides a direct route for inhaled toxins to bypass the BBB entirely, but the barrier itself can also be weakened by stress and other factors. This leakiness allows toxins, heavy metals, and inflammatory molecules to enter the brain, contributing to Parkinson's and Alzheimer's. They note that this understanding is crucial for both preventing disease and developing therapies that can cross the BBB.